Copy For Citation
Pepeler M. S., YILDIZ Ş., YEGİN Z. A., ÖZKURT Z. N., GÜZEL TUNÇCAN Ö., ERBAŞ G., ...More
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, vol.12, no.9, pp.799-805, 2018 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
12
Issue:
9
-
Publication Date:
2018
-
Doi Number:
10.3855/jidc.9961
-
Journal Name:
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.799-805
-
Keywords:
invasive fungal infection, antifungal prophylaxis, voriconazole, amphotericin B, LIPOSOMAL AMPHOTERICIN-B, RISK-FACTORS, HEMATOLOGICAL MALIGNANCIES, MARROW-TRANSPLANTATION, ASPERGILLOSIS, DISEASES, VORICONAZOLE, EXPERIENCE, THERAPY, HISTORY
-
Gazi University Affiliated:
Yes
Abstract
Introduction: Invasive fungal infection (IFI) is a major cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. A previous history of IFI is not an absolute contraindication for allo-HSCT, particularly in the era of secondary antifungal prophylaxis (SAP). Prompt diagnosis and therapy are essential for HSCT outcome.